RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aida Pharmaceuticals Stock

Aida Pharmaceuticals ROE 2025

Aida Pharmaceuticals ROE

0

Ticker

AIDA

ISIN

US0087211027

WKN

A0YHEN

In 2025, Aida Pharmaceuticals's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.

Aida Pharmaceuticals Aktienanalyse

What does Aida Pharmaceuticals do?

Aida Pharmaceuticals Inc is a US-based company that manufactures and distributes pharmaceuticals, dietary supplements, and cosmetic products. The company was founded in 2005 by Dr. Wei Li and is headquartered in Fremont, California. Aida Pharmaceuticals Inc aims to provide a comprehensive alternative for the healthcare industry. It has become a key player in the international market and has expanded its presence on different continents. The company's business model focuses on manufacturing and marketing high-quality products. Aida Pharmaceuticals Inc combines traditional and modern medicine to offer alternative and effective healthcare solutions. The company is divided into three divisions: Pharmaceuticals, offering a variety of prescription drugs tailored to patient needs; Dietary Supplements, providing natural supplements for various health areas; and Cosmetics, offering a wide range of beauty products based on natural ingredients. Aida Pharmaceuticals Inc is known for its quality and effective products, maintaining strict quality standards and selecting the right ingredients. Some of its notable products include Metoprolol for hypertension and heart diseases, Vitamin D3 for bone strength, and Retinol Serum for reducing wrinkles and improving skin structure. Overall, Aida Pharmaceuticals Inc specializes in manufacturing and marketing pharmaceuticals, dietary supplements, and cosmetic products, catering to the diverse health and beauty needs of its customers. The company prioritizes quality and effectiveness and has established itself as a key player in the international market. Aida Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Aida Pharmaceuticals's Return on Equity (ROE)

Aida Pharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Aida Pharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Aida Pharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Aida Pharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Aida Pharmaceuticals stock

What is the ROE (Return on Equity) of Aida Pharmaceuticals this year?

The ROE of Aida Pharmaceuticals this year is 0 undefined.

How has the Return on Equity (ROE) of Aida Pharmaceuticals developed compared to the previous year?

The ROE of Aida Pharmaceuticals has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Aida Pharmaceuticals?

A high ROE indicates that Aida Pharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Aida Pharmaceuticals?

A low ROE can indicate that Aida Pharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Aida Pharmaceuticals affect the company?

A change in ROE (Return on Equity) of Aida Pharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Aida Pharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Aida Pharmaceuticals?

Some factors that can influence Aida Pharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Aida Pharmaceuticals pay?

Over the past 12 months, Aida Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aida Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Aida Pharmaceuticals?

The current dividend yield of Aida Pharmaceuticals is .

When does Aida Pharmaceuticals pay dividends?

Aida Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aida Pharmaceuticals?

Aida Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Aida Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aida Pharmaceuticals located?

Aida Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aida Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aida Pharmaceuticals from 8/25/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2025.

When did Aida Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/25/2025.

What was the dividend of Aida Pharmaceuticals in the year 2024?

In the year 2024, Aida Pharmaceuticals distributed 0 USD as dividends.

In which currency does Aida Pharmaceuticals pay out the dividend?

The dividends of Aida Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aida Pharmaceuticals

Our stock analysis for Aida Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aida Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.